Tuhura Biosciences, INC./NV (HURA) SEC Filings — 2024

Filings

• TuHURA Biosciences Enters Material Definitive Agreement — 8-K · Dec 12, 2024
• TuHURA Biosciences Files 8-K — 8-K · Nov 25, 2024
• TuHURA Biosciences Reports Board Changes and Compensation Updates — 8-K · Nov 15, 2024
• TuHURA Biosciences 10-Q: Merger, Warrants, and Preferred Stock — 10-Q · Nov 14, 2024
• Bianco Files 13D for TuHURA Biosciences — SC 13D · Oct 25, 2024
• Kintara Therapeutics Reports Material Definitive Agreement & Acquisition — 8-K · Oct 21, 2024
• Kintara Therapeutics Files 8-K — 8-K · Oct 15, 2024
• Kintara Therapeutics Files 8-K — 8-K · Oct 8, 2024
• Kintara Therapeutics Files 2024 10-K — 10-K · Oct 7, 2024
• Kintara Therapeutics Files 8-K on Security Holder Vote — 8-K · Oct 4, 2024
• Kintara Therapeutics Files 8-K for Material Agreement — 8-K · Sep 25, 2024
• Kintara Therapeutics Files 8-K — 8-K · Sep 24, 2024
• Kintara Therapeutics Files 8-K with Shareholder Vote and Financial Updates — 8-K · Sep 20, 2024
• Kintara Therapeutics Files 8-K — 8-K · Sep 19, 2024
• Kintara Therapeutics Files 8-K — 8-K · Sep 18, 2024
• Kintara Therapeutics Files 8-K — 8-K · Sep 11, 2024
• Kintara Therapeutics Files 8-K — 8-K · Sep 9, 2024
• Kintara Therapeutics Files 8-K — 8-K · Sep 3, 2024
• Kintara Therapeutics Files 8-K — 8-K · Aug 19, 2024
• Kintara Therapeutics Files 8-K — 8-K · Jul 12, 2024
• Kintara Therapeutics to be Acquired by DelMar Pharmaceuticals — 8-K · Jul 8, 2024